Last 12 months
Inside the activity.
1 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 05, 2025 Filed Jun 9, 2025 11:08 UTC |
GRUA PETER JDirector
|
GrantClass A Common Stock | 21,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000080 · wk-form4_1749467307.xml · nonDerivative · entry 1 GRUA PETER J · CIK 0001242813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,728 F1 · security: Represents restricted stock units granted to Mr. Grua pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 11:18 UTC |
GUERTIN SHAWN MDirector
|
GrantClass A Common Stock | 21,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000094 · wk-form4_1749467905.xml · nonDerivative · entry 1 GUERTIN SHAWN M · CIK 0001231553 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,979 F1 · security: Represents restricted stock units granted to Mr. Guertin pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 11:10 UTC |
Barbarosh Craig A.Director
|
GrantClass A Common Stock | 21,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000082 · wk-form4_1749467441.xml · nonDerivative · entry 1 Barbarosh Craig A. · CIK 0001472457 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,935 F1 · security: Represents restricted stock units granted to Mr. Barbarosh pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 11:13 UTC |
Scott CherylDirector
|
GrantClass A Common Stock | 21,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000088 · wk-form4_1749467620.xml · nonDerivative · entry 1 Scott Cheryl · CIK 0001656979 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,476 F1 · security: Represents restricted stock units granted to Ms. Scott pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| June 05, 2025 Filed Jun 9, 2025 11:06 UTC |
Ajayi ToyinDirector
|
GrantClass A Common Stock | 21,979 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000076 · wk-form4_1749467175.xml · nonDerivative · entry 1 Ajayi Toyin · CIK 0001988404 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,074 F1 · security: Represents restricted stock units granted to Dr. Ajayi pursuant to the Amended and Restated Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of June 5, 2026, and the date of the Company's 2026 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 12:04 UTC |
KECK KIMDirector
|
PurchaseClass A Common Stock | 10,540 | $9.44 | $99,497.60 |
DisclosureSEC source: 0001628908-25-000038 · wk-form4_1741608288.xml · nonDerivative · entry 1 KECK KIM · CIK 0001818332 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,522 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.09-$9.47, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 12:16 UTC |
Jelinek Richard MDirector
|
PurchaseClass A Common Stock | 15,000 | $9.09 | $136,350.00 |
DisclosureSEC source: 0001628908-25-000048 · wk-form4_1741608974.xml · nonDerivative · entry 2 Jelinek Richard M · CIK 0001707429 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Richard M Jelinek GST Disclosed balance after: 15,000 Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 12:16 UTC |
Jelinek Richard MDirector
|
PurchaseClass A Common Stock | 15,000 | $9.16 | $137,400.00 |
DisclosureSEC source: 0001628908-25-000048 · wk-form4_1741608974.xml · nonDerivative · entry 1 Jelinek Richard M · CIK 0001707429 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By the Richard M Jelinek Revocable Trust Disclosed balance after: 15,000 Read SEC document |
| March 07, 2025 Filed Mar 10, 2025 12:10 UTC |
Springstubb Brendan BDirector
|
PurchaseClass A Common Stock | 15,000 | $9.27 | $139,050.00 |
DisclosureSEC source: 0001628908-25-000042 · wk-form4_1741608599.xml · nonDerivative · entry 1 Springstubb Brendan B · CIK 0001687656 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,842 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13-9.45, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 12:07 UTC |
Glass Russell MonroeDirector
|
PurchaseClass A Common Stock | 5,400 | $9.27 | $50,058.00 |
DisclosureSEC source: 0001628908-25-000040 · wk-form4_1741608419.xml · nonDerivative · entry 1 Glass Russell Monroe · CIK 0002012340 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,272 F1 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 08:20 UTC |
Holder DianeDirector
|
PurchaseClass A Common Stock | 2,735 | $9.33 | $25,517.55 |
DisclosureSEC source: 0001628908-25-000052 · wk-form4_1741609247.xml · nonDerivative · entry 1 Holder Diane · CIK 0001642976 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,584 F1 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 12:13 UTC |
GRUA PETER JDirector
|
PurchaseClass A Common Stock | 11,040 | $9.01 | $99,470.40 |
DisclosureSEC source: 0001628908-25-000046 · wk-form4_1741608810.xml · nonDerivative · entry 1 GRUA PETER J · CIK 0001242813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,749 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.74-9.34, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 12:02 UTC |
Barbarosh Craig A.Director
|
PurchaseClass A Common Stock | 2,000 | $8.81 | $17,620.00 |
DisclosureSEC source: 0001628908-25-000036 · wk-form4_1741608122.xml · nonDerivative · entry 1 Barbarosh Craig A. · CIK 0001472457 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,956 F1 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 12:18 UTC |
McCarthy Daniel JosephPRESIDENT
|
PurchaseClass A Common Stock | 11,040 | $9.01 | $99,470.40 |
DisclosureSEC source: 0001628908-25-000050 · wk-form4_1741609085.xml · nonDerivative · entry 1 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,004 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.74-$9.34, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 12:11 UTC |
Blackley SethDirector · Chief Executive Officer
|
PurchaseClass A Common Stock | 55,225 | $9.01 | $497,577.25 |
DisclosureSEC source: 0001628908-25-000044 · wk-form4_1741608697.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 762,217 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.74-9.34, inclusive. The reporting person undertakes to provide to Evolent Health, Inc., any security holder of Evolent Health, Inc., or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 04, 2025 Filed Mar 5, 2025 22:28 UTC |
Springstubb Brendan BDirector
|
PurchaseClass A Common Stock | 5,000 | $8.75 | $43,750.00 |
DisclosureSEC source: 0001628908-25-000034 · wk-form4_1741213710.xml · nonDerivative · entry 2 Springstubb Brendan B · CIK 0001687656 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,842 Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:18 UTC |
Shams AammaadChief Accounting Officer
|
Tax withholdingClass A Common Stock | 3,168 | $8.77 | $27,783.36 |
DisclosureSEC source: 0001628908-25-000028 · wk-form4_1741130295.xml · nonDerivative · entry 4 Shams Aammaad · CIK 0001815354 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,466 F6 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:18 UTC |
Shams AammaadChief Accounting Officer
|
GrantClass A Common Stock | 6,650 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000028 · wk-form4_1741130295.xml · nonDerivative · entry 3 Shams Aammaad · CIK 0001815354 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,634 F5 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:18 UTC |
Shams AammaadChief Accounting Officer
|
GrantClass A Common Stock | 25,151 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000028 · wk-form4_1741130295.xml · nonDerivative · entry 2 Shams Aammaad · CIK 0001815354 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,984 F3 · security: Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F4 · shares: Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:15 UTC |
Weinberg JonathanGeneral Counsel
|
Tax withholdingClass A Common Stock | 3,544 | $8.77 | $31,080.88 |
DisclosureSEC source: 0001628908-25-000026 · wk-form4_1741130128.xml · nonDerivative · entry 4 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 230,785 F6 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:15 UTC |
Weinberg JonathanGeneral Counsel
|
GrantClass A Common Stock | 10,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000026 · wk-form4_1741130128.xml · nonDerivative · entry 3 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,329 F5 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:15 UTC |
Weinberg JonathanGeneral Counsel
|
GrantClass A Common Stock | 65,470 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000026 · wk-form4_1741130128.xml · nonDerivative · entry 2 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,689 F3 · security: Represents restricted stock units granted to Mr. Weinberg pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F4 · shares: Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 02:02 UTC |
Rafferty Emily AnnChief Operating Officer
|
Tax withholdingClass A Common Stock | 2,433 | $8.77 | $21,337.41 |
DisclosureSEC source: 0001628908-25-000032 · wk-form4_1741140149.xml · nonDerivative · entry 4 Rafferty Emily Ann · CIK 0001983577 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 130,128 F6 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 02:02 UTC |
Rafferty Emily AnnChief Operating Officer
|
GrantClass A Common Stock | 5,490 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000032 · wk-form4_1741140149.xml · nonDerivative · entry 3 Rafferty Emily Ann · CIK 0001983577 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,561 F5 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 02:02 UTC |
Rafferty Emily AnnChief Operating Officer
|
GrantClass A Common Stock | 72,937 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000032 · wk-form4_1741140149.xml · nonDerivative · entry 2 Rafferty Emily Ann · CIK 0001983577 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,071 F3 · security: Represents restricted stock units granted to Ms. Rafferty pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F4 · shares: Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 01:56 UTC |
McCarthy Daniel JosephPRESIDENT
|
Tax withholdingClass A Common Stock | 39,501 | $8.77 | $346,423.77 |
DisclosureSEC source: 0001628908-25-000030 · wk-form4_1741139788.xml · nonDerivative · entry 4 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 377,964 F6 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 01:56 UTC |
McCarthy Daniel JosephPRESIDENT
|
GrantClass A Common Stock | 87,585 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000030 · wk-form4_1741139788.xml · nonDerivative · entry 3 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 417,465 F5 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 01:56 UTC |
McCarthy Daniel JosephPRESIDENT
|
GrantClass A Common Stock | 156,683 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000030 · wk-form4_1741139788.xml · nonDerivative · entry 2 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 329,880 F3 · security: Represents restricted stock units granted to Mr. McCarthy pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F4 · shares: Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:09 UTC |
Johnson John PaulChief Financial Officer
|
Tax withholdingClass A Common Stock | 26,872 | $8.77 | $235,667.44 |
DisclosureSEC source: 0001628908-25-000022 · wk-form4_1741129767.xml · nonDerivative · entry 4 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,784 F6 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:09 UTC |
Johnson John PaulChief Financial Officer
|
GrantClass A Common Stock | 59,582 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000022 · wk-form4_1741129767.xml · nonDerivative · entry 3 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,656 F5 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:09 UTC |
Johnson John PaulChief Financial Officer
|
GrantClass A Common Stock | 89,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000022 · wk-form4_1741129767.xml · nonDerivative · entry 2 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 251,074 F3 · security: Represents restricted stock units granted to Mr. Johnson pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F4 · shares: Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:12 UTC |
Blackley SethDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 72,768 | $8.77 | $638,175.36 |
DisclosureSEC source: 0001628908-25-000024 · wk-form4_1741129956.xml · nonDerivative · entry 4 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 706,992 F6 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon settlement of performance-based share units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:12 UTC |
Blackley SethDirector · Chief Executive Officer
|
GrantClass A Common Stock | 161,346 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000024 · wk-form4_1741129956.xml · nonDerivative · entry 3 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 779,760 F5 · shares: Represents the number of shares received upon the settlement of the performance-based share units (PSUs) awarded to the reporting person on March 1, 2022, following the certification of achievement of specified performance metrics by the Compensation Committee of the Company's Board of Directors on March 3, 2025. The shares underlying the PSU award vested at the conclusion of the performance period on December 31, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 23:12 UTC |
Blackley SethDirector · Chief Executive Officer
|
GrantClass A Common Stock | 235,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000024 · wk-form4_1741129956.xml · nonDerivative · entry 2 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 618,414 F3 · security: Represents restricted stock units granted to Mr. Blackley pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F4 · shares: Securities vest at a rate of 34% on March 3, 2026, and 33% on March 3, 2027, and March 3, 2028. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:28 UTC |
Springstubb Brendan BDirector
|
GrantClass A Common Stock | 6,842 | $0.00 | $0.00 |
DisclosureSEC source: 0001628908-25-000034 · wk-form4_1741213710.xml · nonDerivative · entry 1 Springstubb Brendan B · CIK 0001687656 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,842 F1 · security: Represents restricted stock units granted to Mr. Springstubb pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan. F2 · shares: Securities vest on the earlier of March 3, 2026, and the date of the Company's 2025 annual meeting, subject to the reporting person's continued service on the vesting date. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:18 UTC |
Shams AammaadChief Accounting Officer
|
Tax withholdingClass A Common Stock | 5,546 | $8.99 | $49,858.54 |
DisclosureSEC source: 0001628908-25-000028 · wk-form4_1741130295.xml · nonDerivative · entry 1 Shams Aammaad · CIK 0001815354 · Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,833 F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:15 UTC |
Weinberg JonathanGeneral Counsel
|
Tax withholdingClass A Common Stock | 8,808 | $8.99 | $79,183.92 |
DisclosureSEC source: 0001628908-25-000026 · wk-form4_1741130128.xml · nonDerivative · entry 1 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,219 F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 02:02 UTC |
Rafferty Emily AnnChief Operating Officer
|
Tax withholdingClass A Common Stock | 9,274 | $8.99 | $83,373.26 |
DisclosureSEC source: 0001628908-25-000032 · wk-form4_1741140149.xml · nonDerivative · entry 1 Rafferty Emily Ann · CIK 0001983577 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,134 F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2025 Filed Mar 5, 2025 01:56 UTC |
McCarthy Daniel JosephPRESIDENT
|
Tax withholdingClass A Common Stock | 15,143 | $8.99 | $136,135.57 |
DisclosureSEC source: 0001628908-25-000030 · wk-form4_1741139788.xml · nonDerivative · entry 1 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 173,197 F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:09 UTC |
Johnson John PaulChief Financial Officer
|
Tax withholdingClass A Common Stock | 9,246 | $8.99 | $83,121.54 |
DisclosureSEC source: 0001628908-25-000022 · wk-form4_1741129767.xml · nonDerivative · entry 1 Johnson John Paul · CIK 0001782040 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,961 F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 23:12 UTC |
Blackley SethDirector · Chief Executive Officer
|
Tax withholdingClass A Common Stock | 28,535 | $8.99 | $256,529.65 |
DisclosureSEC source: 0001628908-25-000024 · wk-form4_1741129956.xml · nonDerivative · entry 1 Blackley Seth · CIK 0001643346 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,389 F1 · shares: This number represents shares of Class A Common Stock withheld to satisfy the tax withholding obligation due upon vesting of restricted stock units. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 00:16 UTC |
McCarthy Daniel JosephPRESIDENT
|
SaleClass A Common Stock | 4,000 | $33.00 | $132,000.00 |
DisclosureSEC source: 0001628908-24-000100 · wk-form4_1724717792.xml · nonDerivative · entry 5 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 188,340 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 23, 2024 Filed Aug 27, 2024 00:16 UTC |
McCarthy Daniel JosephPRESIDENT
|
SaleClass A Common Stock | 6,469 | $32.00 | $207,008.00 |
DisclosureSEC source: 0001628908-24-000100 · wk-form4_1724717792.xml · nonDerivative · entry 4 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,340 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:14 UTC |
Weinberg JonathanGeneral Counsel
|
Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 16,887 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001628908-24-000098 · wk-form4_1724717691.xml · derivative · entry 6 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 16,887 shares Expires 2025-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024. F4 · derivative.exercise_date: The Class A Common Stock Options exercised vested on June 4, 2016, June 4, 2017, June 4, 2018, and June 4, 2019. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:14 UTC |
Weinberg JonathanGeneral Counsel
|
Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 25,253 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001628908-24-000098 · wk-form4_1724717691.xml · derivative · entry 5 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 25,253 shares Expires 2028-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024. F3 · derivative.exercise_date: The Class A Common Stock Options exercised vested on February 1, 2019, February 1, 2020, February 1, 2021, and February 1, 2022. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:14 UTC |
Weinberg JonathanGeneral Counsel
|
SaleClass A Common Stock | 16,887 | $30.00 | $506,610.00 |
DisclosureSEC source: 0001628908-24-000098 · wk-form4_1724717691.xml · nonDerivative · entry 4 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,027 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:14 UTC |
Weinberg JonathanGeneral Counsel
|
Exercise / conversionClass A Common Stock | 16,887 | $17.00 | $287,079.00 |
DisclosureSEC source: 0001628908-24-000098 · wk-form4_1724717691.xml · nonDerivative · entry 3 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,914 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:14 UTC |
Weinberg JonathanGeneral Counsel
|
SaleClass A Common Stock | 25,253 | $32.00 | $808,096.00 |
DisclosureSEC source: 0001628908-24-000098 · wk-form4_1724717691.xml · nonDerivative · entry 2 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,027 F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:14 UTC |
Weinberg JonathanGeneral Counsel
|
Exercise / conversionClass A Common Stock | 25,253 | $13.95 | $352,279.35 |
DisclosureSEC source: 0001628908-24-000098 · wk-form4_1724717691.xml · nonDerivative · entry 1 Weinberg Jonathan · CIK 0001642833 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2024. F2 · balance_after: Includes restricted stock units granted under awards reported on Table 1 of Form 4s previously filed with the Securities and Exchange Commission. Read SEC document |
| August 22, 2024 Filed Aug 27, 2024 00:16 UTC |
McCarthy Daniel JosephPRESIDENT
|
Exercise / conversionClass A Common Stock Option (right to buy) · Derivative | 4,550 | $0.00 Strike: $24.75 | $0.00 |
DisclosureSEC source: 0001628908-24-000100 · wk-form4_1724717792.xml · derivative · entry 6 McCarthy Daniel Joseph · CIK 0001946147 · PRESIDENT 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 4,550 shares Expires 2027-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024. F3 · derivative.exercise_date: The Class A Common Stock Options exercised vested on August 1, 2018, August 1, 2019, August 1, 2020, and August 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.